GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mersana Therapeutics Inc (STU:0M4) » Definitions » Purchase Of Investment

Mersana Therapeutics (STU:0M4) Purchase Of Investment : €-122.43 Mil (TTM As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Mersana Therapeutics Purchase Of Investment?

Mersana Therapeutics's purchase of investment for the three months ended in Dec. 2024 was €0.00 Mil. It means Mersana Therapeutics spent €0.00 Mil on purchasing investments. Mersana Therapeutics's purchase of investment for the trailing twelve months (TTM) ended in Dec. 2024 was €-122.43 Mil.

Compared with last quarter (€-23.90 Mil in Sep. 2024 ), Mersana Therapeutics spent less money on purchasing investments in Dec. 2024 (€0.00 Mil).

Mersana Therapeutics Purchase Of Investment Historical Data

The historical data trend for Mersana Therapeutics's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mersana Therapeutics Purchase Of Investment Chart

Mersana Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -233.66 -142.98 -127.43

Mersana Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22.44 -80.42 -18.10 -23.90 -

Mersana Therapeutics Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-122.43 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mersana Therapeutics Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Mersana Therapeutics's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Mersana Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mersana Therapeutics Inc (STU:0M4) » Definitions » Purchase Of Investment
Comparable Companies
VRCA MURA FBRX FBLG ANEB ITRM IPSC XLO ATRA KPTI VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
MRSN:USA
Address
840 Memorial Drive, Cambridge, MA, USA, 02139
Website
https://www.mersana.com
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

Mersana Therapeutics Headlines

No Headlines